Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 1 14Phase 1/2 9Phase 3 4Phase NA 2Phase 4 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

NETWORK 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4

Conditions

Carcinoma, Non-Small-Cell Lung 147Breast Neoplasms 116Prostatic Neoplasms 61Multiple Myeloma 57Neoplasms 56Lung Neoplasms 50Neoplasm Metastasis 43Ovarian Neoplasms 36Parkinson Disease 4, Autosomal Dominant Lewy Body 35Colorectal Neoplasms 34Leukemia, Lymphocytic, Chronic, B-Cell 33Carcinoma, Renal Cell 27Recurrence 26Leukemia, Myeloid, Acute 26Urinary Bladder Neoplasms 25Carcinoma, Hepatocellular 24Small Cell Lung Carcinoma 23Myasthenia Gravis 22Triple Negative Breast Neoplasms 21Squamous Cell Carcinoma of Head and Neck 20Lymphoma, Large B-Cell, Diffuse 20Endometrial Neoplasms 20Melanoma 19Lymphoma, Follicular 19Nasopharyngeal Carcinoma 18Fallopian Tube Neoplasms 18Stomach Neoplasms 17Non-Muscle Invasive Bladder Neoplasms 16Brain Neoplasms 16Pancreatic Neoplasms 15

Interventions

pegaspargase 3calaspargase pegol 3Asparaginase 3merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2blinatumomab 2azathiopurine 2auricularum 2Vincristine 2Thioguanine 2Specimen Handling 2Prednisolone 2Methylprednisolone 2Methotrexate 2Mercaptopurine 2Leucovorin 2Doxorubicin 2Dexamethasone 2Daunorubicin 2Cytarabine 2Cyclophosphamide 2Calcium Dobesilate 2prednylidene 1exifone 1deltacortene 1Stem Cell Transplantation 1Razoxane 1Radiotherapy 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Biphenotypic, Acute × 90 days × Clear all
NCT05602194 2026-06-02

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Children's Oncology Group

Phase 3 Active not recruiting
440 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT03959085 2026-05-05

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Children's Oncology Group

Phase 3 Recruiting
5,951 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Biphenotypic, Acute

NCT03007147 2026-05-04

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Active not recruiting
475 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT05327894 2026-04-13

Interfant-21

Princess Maxima Center for Pediatric Oncology

Phase 3 Recruiting
160 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡